Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?

European Journal of Clinical Investigation

Volumn 35, Issue 2, 2005, Pages 117-125

  Kriketos, A ^a   Milner, K L ^b   Denyer, G ^c   Campbell, Lesley ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Fat meal; Insulin resistance; Lipid metabolism; Obesity; Type 2 diabetes

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CALORIC INTAKE; CARBOHYDRATE DIET; CLINICAL ARTICLE; FAMILY HISTORY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; RELATIVE; STATISTICAL ANALYSIS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD;

EID: 13544251380     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01458.x     Document Type: Article

References (32)

1. Reaven G. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-85.
3. Boquist S, Hamsten A, Karpe F, Ruotolo G. Insulin and nonesterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men. Diabetologia 2000;43:185-93.
4. Brown A-M, Gibbons GF. Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase mediated event. Arterioscler Thromb Vasc Biol 2001;21:1656-61.
5. Malmstrum R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Yarvinen H et al. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 1998;47:779-87.
6. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 1988;37:982-7.
7. Olefsky JM, Farquhar JW, Reaven GM. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 1974;57:551-60.
8. Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967;46:1756-67.
9. Tobey TA, Greenfield M, Kraemer F, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism 1981;30:165-71.
10. Kriketos AD, Sam W, Schubert T, Maclean E, Campbell LV. Postprandial triglycerides in response to high fat: role of dietary carbohydrate. Eur J Clin Invest 2003;33:383-9.
11. Westphal S, Leodolter A, Kahl S, Dierkes J, Malfertheiner P, Luley C. Addition of glucose to a fatty meal delays chylomicrons and suppresses VLDL in healthy subjects. Eur J Clin Invest 2002;32:322-7.
12. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Defects in insulin secretion and insulin action in noninsulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 1998;101:86-96.
13. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C et al. Early metabolic defects in persons at increased risk for noninsulin-dependent diabetes mellitus. N Engl J Med 1989;321:337-43.
14. Kriketos AD, Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV. Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab 2003;88:793-8.
15. Axelsen M, Eriksson JW, Taskinen M-R, Jansson P-A. Postprandial hypertriglyceridaemia and insulin resistance in normoglycaemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med 1999;131:27-31.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:11893-7.
17. Carey D, Jenkins A, Campbell L, Freund J, Chisholm D. Abdominal fat and insulin resistance in normal and overweight women. Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45:633-8.
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique. A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
19. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-34.
20. Dubois C, Beaumier G, Juhel G, Armand M, Portugal H, Pauli AM et al. Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidaemic adults. Am J Clin Nutr 1998;67:31-8.
21. Chen YD, Skowronski R, Coulston AM, Pietarinen J, Hollenbeck CB, Reaven GM. Effect of acute variations in dietary fat and carbohydrate intake on retinyl ester content of intestinally derived lipoproteins. J Clin Endocrinol Metab 1992;74:28-32.
22. Cohen JC, Schall R. Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. Am J Clin Nutr 1988;48:1031-4.
23. Vergès B, Guerci B, Durlach V, Galland-Jos C, Paul JL, Lagrost L et al. Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects. J Lipid Res 2001;42:2021-9.
24. Jeppesen J, Chen YD, Zhou MY, Wang T, Reaven GM. Effect of variations in oral fat load and carbohydrate load on postprandial lipaemia. Am J Clin Nutr 1995;62:1201-5.
25. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999;246:341-55.
26. Johanson EH, Jansson PA, Gustafson B, Lonn L, Smith U, Taskinen MR et al. Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes. J Intern Med 2004;255:273-9.
27. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999;42:128-38.
28. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA et al. Inflammation, insulin resistance and adiposity: a study of first degree relatives of type 2 diabetic subjects. Diabetes Care 2004;27:2033-40.
29. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-71.
30. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Pettiti M, Natali A et al. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 2003;46:1211-9.
31. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003;52:2461-74.
32. Lefevre M, Kris-Etherton PM, Zhao G, Tracy RR. Dietary fatty acids, hemostasis, and cardiovascular disease risk. J Am Diet Assoc 2004;104:410-9.